Ultrasound assessment of cerebrovascular risk via breath-holding index in migraine patients treated with anti-CGRP monoclonal antibodies: a pilot study.

Aimovig (erenumab-aooe) - Amgen

Emgality (galcanezumab-gnlm) - Eli Lilly, Daiichi Sankyo

Ajovy (fremanezumab-vfrm) - Teva

http://www.ncbi.nlm.nih.gov/pubmed/42602332

Gianvito Barbella; Ilaria Casetta; Marina Padroni; Maurizio Paciaroni; Pietro Antenucci; Vittorio Govoni

Aug 16, 2026